The U.S. Food and Drug Administration has approved a new drug, Krystexxa (pegloticase), to treat painful gout in adults who do not respond to or cannot tolerate usual therapy. – (AHN)
Read the original post by KSWB-TV San Diego
Consumer Electronics in the News
The U.S. Food and Drug Administration has approved a new drug, Krystexxa (pegloticase), to treat painful gout in adults who do not respond to or cannot tolerate usual therapy. – (AHN)
Read the original post by KSWB-TV San Diego